Adipokine and cytokine levels in non-functioning adrenal incidentalomas (NFAI)-Reference-Cited by-同舟云学术

Adipokine and cytokine levels in non-functioning adrenal incidentalomas (NFAI)

Published:2018 Issue:8 Volume:65 Page:849-858
ISSN:0918-8959
Container-title:Endocrine Journal
language:en
Short-container-title:Endocr J

Author:

Babinska Anna¹,Kaszubowski Mariusz²,Sworczak Krzysztof¹

Affiliation:

1. Department of Endocrinology and Internal Medicine, Medical University of Gdansk, Gdansk, Poland

2. Institute of Statistics, Department of Economic Sciences, Faculty of Management and Economics, Gdansk University of Technology, Gdansk, Poland

Publisher

Japan Endocrine Society

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism

Link

https://www.jstage.jst.go.jp/article/endocrj/65/8/65_EJ18-0066/_pdf

Reference56 articles.

1. 1 Griffing GT (1994) AIDS: the new endocrine epidemic. J Clin Endocrinol Metab 79: 1530–1531.

2. 2 Bittner JG, Brunt LM (2012) Evaluation and management of adrenal incidentaloma. J Surg Oncol 106: 557–564.

3. 3 Otto M (2010) Surgical treatment of adrenal tumors. Endokrynol Pol 61: 716–722.

4. 4 Bednarczuk T, Bolanowski M, Sworczak K, Gornicka B, Cieszanowski A, et al. (2016) Adrenal incidentaloma in adults—management recommendations by the Polish Society of Endocrinology. Endokrynol Pol 67: 234–258.

5. 5 Mantero F, Terzolo M, Arnaldi G, Osella G, Masini AM, et al. (2000) A survey on adrenal incidentaloma in Italy. Study Group on Adrenal Tumors of the Italian Society of Endocrinology. J Clin Endocrinol Metab 85: 637–644.

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Increased cardiometabolic risk and prevalence of ascending aorta dilation in patients with nonfunctioning adrenal incidentaloma: a retrospective propensity score-matched study;Hypertension Research;2024-08-01

2. Serum Visfatin/NAMPT as a Potential Risk Predictor for Malignancy of Adrenal Tumors;Journal of Clinical Medicine;2022-09-22

3. A retrospective study on the association between urine metanephrines and cardiometabolic risk in patients with nonfunctioning adrenal incidentaloma;Scientific Reports;2022-09-01

4. New Biomarkers to Predict Cardiovascular Risk in Patients with Adrenal Incidentaloma; Irisin and Nesfatin-1;Acta Endocrinologica (Bucharest);2022

5. Cross-Talk Between Nitrosative Stress, Inflammation and Hypoxia-Inducible Factor in Patients with Adrenal Masses;Journal of Inflammation Research;2021-11